Cardiac involvement in systemic lupus erythematosus

Lupus

Volumn 14, Issue 9, 2005, Pages 683-686

  Doria, Andrea ^a   Iaccarino, L ^a   Sarzi Puttini, P ^b   Atzeni, F ^b   Turriel, M ^c   Petri, M ^d  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diagnosis; Echocardiography; Heart; Pathogenesis; Systemic lupus erythematosus; Treatment

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHOLIPID ANTIBODY; PREDNISONE;

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL OCCLUSION; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; DRUG MEGADOSE; ECHOCARDIOGRAPHY; ENDOCARDITIS; HEART ARRHYTHMIA; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; MYOCARDIAL DISEASE; MYOCARDITIS; PERICARDITIS; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMIC LUPUS ERYTHEMATOSUS; VALVULAR HEART DISEASE; VASCULITIS;

CARDIOVASCULAR DISEASES; CORONARY VESSELS; ECHOCARDIOGRAPHY; HEART; HEART CONDUCTION SYSTEM; HEART VALVES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MYOCARDITIS; PERICARDITIS;

EID: 26244447527     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203305lu2200oa     Document Type: Review

References (34)

1. D'Cruz D, Khamashta M, Huges GRV. Cardiovascular manifestation of systemic lupus erythematosus. In Wallace DJ and Hahn BH, eds. Dubois' lupus erythematosus, Philadelphia: Lippincott Williams & Wilkins, 2001: 645.
2. Kao AH, Manzi S. How to manage patients with cardiopulmonary disease? Best Pract Res Clin Rheumatol 2002; 16: 211-227.
3. Doria A, Petri M. Cardiac involvement in systemic lupus erythematosus. In Doria A, Pauletto P, eds. The heart in systemic autoimmune disease. Amsterdam: Elsevier, Amsterdam, 2004: 146-162.
4. Bidani AK, Roberts JL, Schwartz MM et al. Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med 1980; 69: 849-858.
5. Ramonda R, Doria A, Villanova C et al. Évaluation de l'atteinte cardiaque au cours du lupus érythémateux disséminé: étude clinique et échocardiographique. Rev Rhum Mol Ostéoartic 1992; 59: 790-796.
6. Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med 1924; 33: 701-737.
7. Omdal R, Lunde P, Rasmussen K et al. Transesophageal and trans thoracic echocardiography and Doppler-examination in systemic lupus erythematosus. Scand J Rheumatol 2001; 30: 275-281.
8. Bulkley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy: a study of 36 necropsy patients. Am J Med 1975; 58: 243-264.
9. Doherty NE, Siegel RJ. Cardiovascular manifestation of systemic lupus erythematosus. Am Heart J 1985; 110: 1257-1265.
10. Leszczynski P, Straburzynska-Migaj E, Korczowska I, Lacki JK, Mackiewicz S. Cardiac valvular disease in patients with systemic lupus erythematosus. Relationship with anticardiolipin antibodies. Clin Rheumatol 2003; 22: 405-408.
11. Eiken PW, Edwards WD, Tazelaar HD et al. Surgical pathology of nonbacterial thrombotic endocarditis in 30 patients, 1985-2000. Mayo Clin Proc 2001; 76: 1204-1212.
12. Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Eng J Med 1996; 335: 1424-1430.
13. Jensen-Urstad K, Svenungsson E, de Faire U et al. Cardiac valvular abnormalities are frequent in systemic lupus erythematosus with manifest arterial disease. Lupus 2002; 11: 744-752.
14. Hakim JP, Mehta A, Jain AC et al. Mitral valve replacement and repair. Report of 5 patients with systemic lupus erythematosus. Tex Heart Inst J 2001; 28: 47-52.
15. Gordon RJ, Weilbaecher D, Davy SM et al. Valvulitis involving a bioprosthetic valve in a patients with systemic lupus erythematosus. J Am Soc Echocardiogr 1996; 9: 104-107.
16. Roberts WC, High ST. The heart in systemic lupus erythematosus. Curr Probl Cardiol 1999; 24: 1-56.
17. Logar D, Kveder T, Rozman B et al. Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus. Ann Rheum Dis 1990; 49: 627-629.
18. Singh JA, Woodard PK, Davila-Roman VG et al. Cardiac magnetic resonance imaging abnormalities in systemic lupus erythematosus: a preliminary report. Lupus 2005; 14: 137-144.
19. Abu-Shakra M, Urowitz MB, Gladman DD et al. Mortality studies in systemic lupus erythematosus. Results from a single centre. I. Causes of death. J Rheumatol 1995; 22: 1259-1270.
20. Petri M, Perez-Gutthann S, Spence D et al. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med 1992; 93: 513-519.
21. Toloza SM, Uribe AG, McGwin G Jr et al. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA). XXIII. Base-line predictors of vascular events. Arthritis Rheum 2004; 50: 3947-3957.
22. Manzi S, Meilahn EN, Rairie JE et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 1997; 145: 408-415.
23. Manger K, Kusus M, Forster C et al. Factors associated with coronary artery calcification in young female patients with SLE. Ann Rheum Dis 2003; 62: 846-850.
24. Doria A, Shoenfeld Y, Wu R et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2003; 62: 1071-1077.
25. Petri M, Spence D, Bone LR et al. Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: Prevalence, recognition by patients and preventing pratices. Medicine 1992; 71: 291-302.
26. Petri M, Lakatta C, Magder L et al. Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: a longitudinal data analysis. Am J Med 1994; 96: 254-259.
27. Petri M, Roubenoff R, Dallal GE et al. Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus. Lancet 1996; 348: 1120-1124.
28. Petri M. Detection of coronary artery disease and the role of traditional risk factors in the Hopkins Lupus Cohort. Lupus 2000; 9: 170-175.
29. Petri M. Hopkins Lupus Cohort. 1999 update. Rheum Dis Clin North Am 2000; 26: 199-213.
30. Roman MJ, Shanker BA, Davis A et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349: 2399-2406.
31. Doria A, Sherer Y, Meroni PL, Shoenfeld Y. Inflammation and accelerated atherosclerosis - basic mechanisms. Rheum Dis Clin N Am 2005; 31: 329-354.
32. Doria A, Shoenfeld Y, Pauletto P. Premature coronary disease in systemic lupus. N Eng J Med 2004; 350: 1571 (letter).
33. Comin-Colet J, Sánches-Corral MA, Alegre-Sancho JJ et al. Complete heart block in an adult with systemic lupus erythematosus and recent onset of hydroxychloroquine therapy. Lupus 2001; 10: 59-62.
34. Brucato A, Doria A, Frassi M et al. Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. Lupus 2002; 11: 716-721.